Since 2012, Ekso Bionics, Inc. has sponsored or supported clinical research using Ekso devices. The vast majority of completed and ongoing studies are investigator-initiated. As of June 2019, there were 65 completed studies and 40 ongoing studies. These 105 studies involve more than 1,800 participants. Roughly half of the research is conducted within the U.S with the remainder within the EMEA. Because the first Ekso device was designed for those with spinal cord injury (SCI), most early research was conducted with SCI participants. With newer hardware and software accommodating more impairments, studies in patients with stroke and other neurological diagnoses have been quickly increasing. As expected, many of the feasibility studies have led to larger studies (single-arm or comparative) where the investment of time and resources is considerable. Ekso Bionics, Inc. remains committed to demonstrating clinical benefit through research. The graph below shows how the areas of the current Ekso research are now more diversified.